Edesa Biotech (EDSA) Accounts Payables (2013 - 2026)
Edesa Biotech (EDSA) posted Accounts Payables of $3.91 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 481.3% from $672,674 a year earlier.
Powered by 
Analysis
Edesa Biotech (EDSA) Accounts Payables (2013 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Edesa Biotech's Accounts Payables came in at $1.08 million, down 40.5% from FY2024.
- Annual Accounts Payables shows a five-year compound annual growth rate of -5.9% (FY2020 to FY2025).
- In prior fiscal years, Edesa Biotech's Accounts Payables was $1.81 million in FY2024 (+3.8%), $1.75 million in FY2023 (-17.7%), $2.12 million in FY2022 (+53.8%) and $1.38 million in FY2021 (-5.5%).
- The fiscal Q3 2026 figure stands as the highest quarterly Accounts Payables since fiscal Q3 2022.
- On a year-over-year basis, Accounts Payables increased in two of the last seven quarters, with growth averaging 36.7%.
- The strongest year-over-year quarter for Accounts Payables in the past five years was fiscal Q3 2022, with growth of 521.4%; the weakest was fiscal Q3 2023, with a decline of 74.1%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.22 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 3.83 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.58 Bn |
| 10 | Edesa Biotech | 26.08 Mn | -19.46 Mn | - | 3.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.91 Mn |
| Dec 31, 2025 | 756,163.00 |
| Sep 30, 2025 | 1.08 Mn |
| Jun 30, 2025 | 672,674.00 |
| Mar 31, 2025 | 914,701.00 |
| Dec 31, 2024 | 1.90 Mn |
| Sep 30, 2024 | 1.81 Mn |
| Jun 30, 2024 | 2.32 Mn |
| Mar 31, 2024 | 2.09 Mn |
| Dec 31, 2023 | 1.91 Mn |
| Sep 30, 2023 | 1.75 Mn |
| Jun 30, 2023 | 1.45 Mn |
| Mar 31, 2023 | 1.50 Mn |
| Dec 31, 2022 | 1.21 Mn |
| Sep 30, 2022 | 2.12 Mn |
| Jun 30, 2022 | 5.62 Mn |
| Mar 31, 2022 | 3.27 Mn |
| Dec 31, 2021 | 1.67 Mn |
| Sep 30, 2021 | 1.38 Mn |
| Jun 30, 2021 | 903,964.00 |
API Access
Edesa Biotech Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=EDSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "EDSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=EDSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();